Preparation, identification, and clinical application of anti-HBs monoclonal antibody that binds both wild-type and immune escape mutant HBsAgs

Frontiers of Medicine in China

Volumn 3, Issue 3, 2009, Pages 277-283

  Li, Fanghe ^a   Zhang, Chunyan ^a   Liu, Jinghua ^a   Zhang, Xiaoyan ^a   Yan, Bing ^a   Zhang, Bo ^a   Huang, Yongguo ^a   Gong, Jingsong ^a   Chen, Yan ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Enzyme linked immunosorbent assay; Gene variation; Hepatitis B surface antigen; Hepatitis B virus; Immune escape

Indexed keywords

EID: 69549114426     PISSN: 16737342     EISSN: 16737458     Source Type: Journal    
DOI: 10.1007/s11684-009-0047-0     Document Type: Article

References (30)

1. Carman WF. The clinical significance of surface antigen variants of hepatitis B virus. J Viral Hepat, 1997, 4(Suppl 1): 11-20
2. Kao J H, Chen D S. Global control of hepatitis B virus. Lancet Infect Dis, 2002, 2(7): 395-403
3. Günther S, Sommer G, Plikat U, Iwanska S, Wain-Hobson S, Will H, Meyerhans A. Naturally occurring hepatitis B virus genomes bearing the hallmarks of retroviral G → A hypermutation. Virology, 1997, 235(1): 104-112
4. Hunt CM, Mcgill JM, Allen M I, Condeady L D. Clinical relevance of hepatitis B viral mutations. Hepatology, 2000, 31(5): 1037-1044
5. Kfoury Baz E M, Zheng J, Mazuruk K, Van Le A, Peterson D L. Characterization of a novel hepatitis B virus mutant: Demonstration of mutation-induced hepatitis B virus surface antigen group specific "a" determinant conformation change and its application in diagnositic assays. Transfus Med, 2001, 11(5): 355-362
6. Weber B. Genetic variability of the S gene of hepatitis B virus: clinical and diagnostic impact. J Clin Virol, 2005, 32(2): 102-112
7. Ogura Y, Kurosaki M, Asshina Y, Asahina Y, Enomoto N, Marumo F, Sato C. Prevalence and significance of naturally occurring mutations in the surface and polymerase genes of hepatitits B virus. J Infect Dis, 1999, 180(5): 1444-1451
8. Poovorawan Y, Theamboomlers A, Chongsrisawat V, Sanpavat S. Molecular analysis of the a determinant of HBsAg in children of HBeAg -positive mother upon failure of postexposure prophylaxis. Int J Infect Dis, 1998, 2(4): 216-220
9. Ngui S L, O'Connell S, Eglin R P, Heptonstall J, Teo C G. Low detecion rate and maternal provernance of hepatitis B virus S gene mutants in cases of failed postnatal immunoprophylaxix in England and Wales. J Infect Dis, 1997, 176(5): 1360-1365
10. Ly T D, Servant-Delmas A, Bagot S, Gonzalo S, Férey M P, Ebel A, Dussaix E, Laperche S, Roque-Afonso A M. Sensitivities of four new commercial hepatitis B virus surface antigen (HBsAg) assays in detection of HBsAg mutant forms. J Clin Microbiol, 2006, 44(7): 2321-2326
11. Wuhan Institute of Biological Products in China. Manufactory protocol of seral HBV vaccine. Inner data in the research shop of HBV vaccine manufacture, Wuhan Institute of Biological Products in China. 1987, 76-89
12. Li F H, Yang D L, Yu Z Q, Wang J C, Wang Y K, Hao L J. Establishment of a cell line with anti-monoclonal antibody with twofold immunoreactivities against both HBsAg and HBcAg. Tong Ji Yi Ke Da Xue Xue Bao, 1994, 23(4): 288-291 (in Chinese)
13. Wuhan Institute of Biological Products in China. Research on the one step quickly hepatitis B virus detection ELISA kits. In research on HBs antigen and HBe antigen detection ELISA Kits with monoclonal antibody (Inner data in Wuhan Institute of Biological Products in China). 1993, 33-47
14. Tian Y J, Qin L, Zhang Z M, Li L, Lie Y C, Yu Z Q, Zhao X P, Yang D L. Study on a transgenic cell line stable expression Cly145Arg mutation HBsAg. Zhong Guo Bing Du Xue, 2005, 20(6): 574-577 (in Chinese)
15. Zhang B, Li F H, Gong J S, Tian Y J, Zhang C Y, Li S J, Chen Y, Huang Y G, Yang D L. Development and Application of Affinity Chromatography for Purification of Recombinant G145R HBsAg. Zhong Guo ShengWu Zhi Ping Xue Za Zhi, 2007, 20(10): 767-770 (in Chinese)
16. Tian Y J, Zhang Z H, Li L, Liu S P, Xu Y, Lu M J, Yang D L. Screening and application of a monoclonal antibody against variant hepatitis B surface antigen. Mian Yi Xue Za Zhi, 2008, 24(1): 56-60 (in Chinese)
17. Qian C, Jiang P, Lu C, Yao K. Preparation and characterization of anti-epitopes of SARS coronavirus M protein monoclonal antibody. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi, 2006, 22(2): 213-217 (in Chinese)
18. Zhang C Y, Gong J S, Zhang X Y, Chen Y, Liu J H, Zhang B, Peng J, Huang Y G, Li F H. detection of the serum G145R mutant relative HBsAg and its clinical significant. Zhong Guo Mian Yi Xue Za Zhi, 2008, 24(12): 63-66 (in Chinese)
19. Zhang D H, Lu Z M. Diagnology of Infectious Disease (in Chinese). Shanghai: Publishing House of Shanghai Science and Technology, 2007, 33-41
20. Weber B. Diagnostic impact of the genetic variability of the hepatitis B virus surface antigen gene. J Med Virol, 2006, 78(Suppl 1): S59-S65
21. Liu J H, Huang Y G, Zhang C Y, Peng J, Zhang X Y, Gong J S, Chen Y, Li F H. Development of a method to detect immune escape mutant HBsAg of widely and its initial sue in clinic. Zhong Guo Shi Yang Zheng Duan Xue, 2008, 12(10): 1199-1203 (in Chinese)
22. Zhang J L, Chen J, Li M N, Zhang L, Zhang J, Guo J J, Xie J. Antivariant hepatitis B surface antigen monoclonal antibody and another eight hepatitis B detectors used for quarantine and their work-efficiency comparison. Zhong Guo Yao Wu Yu Lin Chuang, 2005, 5(11): 814-815 (in Chinese).
23. Cooreman M P, van Roosmalen M H, te Morsche R, Sünnen C M, de Ven E M, Jansen J B, Tytgat G N, de Wit P L, Paulij W P. Characterization of the reactivity pattern of murine monoclonal antibodies against wild type hepatitis B surface antigen to G145R and other naturally occurring a loop escape mutations. Hepatology, 1999, 30(5): 1287-1291
24. Levicnik-Stezinar S. Hepatitis B surface antigen escape mutant in a first time blood donor potentially missed by a routine screening assay. Clin Lab, 2004, 50(1,2): 49-51
25. He J W, Wu L, Yiao X, Li H M, Wen Y M. Antigen expression and DNA immunization of 129Leu and 145Arg variants of hepatitis B virus S gene. Zhong Hua Wei Sheng Wu Xue He Mian Yi Xue Za Zhi, 1999, 19(3): 201-205 (in Chinese)
26. Liu F, Zhang Y P, Ma Z M, Wu L, Wen Y M, He L F. Studies on the mechanism and clinical significance of low immunogenicity of hepatitis B virus"a"determinant 129 leu variant. Zhong Hua Wei Sheng Wu Xue He Mian Yi Xue Za Zhi, 2002, 22(3): 279-283 (in Chinese)
27. Hou J, Karayiannis P, Waters J, Luo K, Liang C, Thomas H C. A unique insertion in the S gene of surface antigen-negative hepatitis B virus Chinese carriers. Hepatology, 1995, 21(2): 273-278
28. Schaefer S. Hepatitis B virus: Significance of genotypes. J Viral Hepat, 2005, 12(2): 111-124
29. Ijaz S, Torre F, Tedder R S, Williams R, Naoumov N V. Novel immunoassay for the detection of hepatitis B surface 'escape' mutants and its application in liver transplant recipients. J Med Virol, 2001, 63(3): 210-216
30. Wuhan Institute of Biological Products in China. Manufactory protocol of seral HBV vaccine. Inner data in the research shop of HBV vaccine manufacture, Wuhan Institute of Biological Products in China. 1987, 76-89